Liam Condon Buys 24 Shares of Johnson Matthey PLC (LON:JMAT) Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon acquired 24 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were bought at an average cost of GBX 1,767 ($22.00) per share, with a total value of £424.08 ($527.92).

Johnson Matthey Trading Down 0.9 %

Shares of Johnson Matthey stock traded down GBX 16 ($0.20) during midday trading on Thursday, reaching GBX 1,753 ($21.82). 354,391 shares of the company’s stock traded hands, compared to its average volume of 694,900. The company has a debt-to-equity ratio of 63.95, a quick ratio of 0.76 and a current ratio of 1.51. The company has a market cap of £3.22 billion, a PE ratio of 1,832.29, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.98. The stock has a 50 day moving average of GBX 1,699.10 and a 200-day moving average of GBX 1,624.93. Johnson Matthey PLC has a 12 month low of GBX 1,428.50 ($17.78) and a 12 month high of GBX 1,986.31 ($24.73).

Analyst Upgrades and Downgrades

JMAT has been the subject of a number of analyst reports. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,100 ($26.14) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. Berenberg Bank increased their price objective on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the company a “hold” rating in a research note on Monday, April 8th. Finally, Numis Securities reissued a “buy” rating and set a GBX 2,200 ($27.39) price objective on shares of Johnson Matthey in a research note on Wednesday, March 20th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,010 ($25.02).

Check Out Our Latest Research Report on JMAT

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Stories

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.